AVITA Medical, Inc.
RCEL
$10.25
$0.181.79%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 29.67% | 43.25% | 29.29% | 5.25% | 50.13% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 29.67% | 43.25% | 29.29% | 5.25% | 50.13% |
| Cost of Revenue | 26.95% | 50.97% | -4.22% | -9.24% | 33.33% |
| Gross Profit | 30.06% | 41.83% | 37.02% | 7.97% | 52.92% |
| SG&A Expenses | 18.18% | 48.50% | 47.27% | 45.62% | 54.04% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | 94.25% |
| Total Operating Expenses | 7.16% | 45.32% | 34.42% | 38.36% | 72.28% |
| Operating Income | 18.87% | -48.36% | -39.84% | -73.61% | -107.74% |
| Income Before Tax | -64.04% | -86.56% | -48.11% | -102.70% | -32.35% |
| Income Tax Expenses | 58.33% | -354.55% | 153.85% | 0.00% | -50.00% |
| Earnings from Continuing Operations | -64.03% | -86.01% | -48.24% | -102.36% | -31.98% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -64.03% | -86.01% | -48.24% | -102.36% | -31.98% |
| EBIT | 18.87% | -48.36% | -39.84% | -73.61% | -107.74% |
| EBITDA | 21.00% | -47.63% | -39.84% | -73.93% | -109.17% |
| EPS Basic | -59.83% | -81.84% | -45.24% | -98.96% | -29.94% |
| Normalized Basic EPS | 16.69% | -71.13% | -45.05% | -99.25% | -152.18% |
| EPS Diluted | -59.83% | -81.84% | -45.24% | -97.30% | -29.94% |
| Normalized Diluted EPS | 16.69% | -71.13% | -45.05% | -99.25% | -152.18% |
| Average Basic Shares Outstanding | 2.62% | 2.29% | 2.06% | 1.73% | 1.57% |
| Average Diluted Shares Outstanding | 2.62% | 2.29% | 2.06% | 1.73% | 1.57% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |